JP2016053063A5 - - Google Patents

Download PDF

Info

Publication number
JP2016053063A5
JP2016053063A5 JP2015217255A JP2015217255A JP2016053063A5 JP 2016053063 A5 JP2016053063 A5 JP 2016053063A5 JP 2015217255 A JP2015217255 A JP 2015217255A JP 2015217255 A JP2015217255 A JP 2015217255A JP 2016053063 A5 JP2016053063 A5 JP 2016053063A5
Authority
JP
Japan
Prior art keywords
protein
hydroxypropylcellulose
composition according
protein composition
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015217255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016053063A (ja
JP6317307B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016053063A publication Critical patent/JP2016053063A/ja
Publication of JP2016053063A5 publication Critical patent/JP2016053063A5/ja
Application granted granted Critical
Publication of JP6317307B2 publication Critical patent/JP6317307B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015217255A 2012-05-14 2015-11-05 放射線滅菌耐性蛋白質組成物 Active JP6317307B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2012110395 2012-05-14
JP2012110764 2012-05-14
JP2012110764 2012-05-14
JP2012110395 2012-05-14
JP2013040594 2013-03-01
JP2013040594 2013-03-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014515697A Division JP5872032B2 (ja) 2012-05-14 2013-05-13 放射線滅菌耐性蛋白質組成物

Publications (3)

Publication Number Publication Date
JP2016053063A JP2016053063A (ja) 2016-04-14
JP2016053063A5 true JP2016053063A5 (enExample) 2016-06-23
JP6317307B2 JP6317307B2 (ja) 2018-04-25

Family

ID=49583865

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014515697A Active JP5872032B2 (ja) 2012-05-14 2013-05-13 放射線滅菌耐性蛋白質組成物
JP2015217255A Active JP6317307B2 (ja) 2012-05-14 2015-11-05 放射線滅菌耐性蛋白質組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014515697A Active JP5872032B2 (ja) 2012-05-14 2013-05-13 放射線滅菌耐性蛋白質組成物

Country Status (17)

Country Link
US (1) US20150132279A1 (enExample)
EP (2) EP3366301A1 (enExample)
JP (2) JP5872032B2 (enExample)
KR (1) KR102112375B1 (enExample)
CN (1) CN104271145B (enExample)
AU (1) AU2013261307B2 (enExample)
BR (1) BR112014028441B1 (enExample)
CA (1) CA2873655C (enExample)
DK (1) DK2851083T3 (enExample)
ES (1) ES2682024T3 (enExample)
IN (1) IN2014DN09624A (enExample)
MX (1) MX355012B (enExample)
PL (1) PL2851083T3 (enExample)
PT (1) PT2851083T (enExample)
RU (1) RU2678828C2 (enExample)
TW (1) TWI590836B (enExample)
WO (1) WO2013172467A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
CN107213479B (zh) * 2017-06-22 2018-12-28 苏州杰纳生物科技有限公司 一种包含过氧化氢酶的组合物及用途
US12178939B2 (en) 2019-01-31 2024-12-31 Cell-Medicine, Inc. Inorganic salt-protein composite medical instrument
WO2021152121A1 (en) * 2020-01-30 2021-08-05 Leukocare Ag Reduction of adsorption

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE785825A (fr) * 1971-07-05 1973-01-04 Ciba Geigy Preparation vegetales d'enzymes contenant peu de germes et procede pourles obtenir
CA2033046C (en) 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
AU682894B2 (en) * 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
JP3648573B2 (ja) * 1995-03-29 2005-05-18 第一工業製薬株式会社 カルボキシメチルセルロースナトリウム塩の溶解方法
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5730933A (en) * 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
DE59913287D1 (de) * 1998-11-18 2006-05-18 Zlb Behring Gmbh Stabilisierte proteinzubereitungen für einen gewebekleber
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
US6749851B2 (en) * 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
JP2005505581A (ja) * 2001-10-03 2005-02-24 クリストファー ジェイ ウールヴァートン 貯蔵安定なヒトフィブリノーゲン溶液
CA2506839A1 (en) * 2002-11-20 2004-06-03 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
DK1809343T3 (da) * 2004-10-20 2012-11-26 Ethicon Inc Forstærket absorberbar hæmostatisk flerlagssårforbinding samt fremstillingsfremgangsmåde
GB0505975D0 (en) 2005-03-23 2005-04-27 Queen Mary & Westfield College Novel use of peptide
EP2130549B1 (en) 2007-03-22 2014-07-16 The Chemo-Sero-Therapeutic Research Institute Solid fibrinogen preparation
EP2143440A1 (fr) * 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
GB0909131D0 (en) * 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
JP5555928B2 (ja) 2009-08-28 2014-07-23 日本バイリーン株式会社 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置
RU2535869C2 (ru) * 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения

Similar Documents

Publication Publication Date Title
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
BR112015023513A2 (pt) métodos de purificação de rna
EA201790630A1 (ru) Способы получения рибозидов
WO2015056237A3 (en) Purification of proteins
WO2015028969A3 (en) Transduction buffer
JP2013032389A5 (enExample)
BR112015021923A2 (pt) composições de limpeza contendo uma polieteramina, um polímero removedor de sujeiras e uma carboximetil-celulose
EA201791998A1 (ru) Альдегиды для лечения легочного фиброза, гипоксии и заболевания соединительной ткани и аутоиммунного заболевания
JP2015520667A5 (enExample)
EA201591276A1 (ru) Фармацевтическая композиция с улучшенной биодоступностью
EA201491644A1 (ru) Фармацевтические композиции
JP2015164127A5 (enExample)
JP2010501534A5 (enExample)
NZ721952A (en) Delayed release compositions of linaclotide
JP2016053063A5 (enExample)
HRP20220313T1 (hr) Procesi za pripremu spojeva sličnih oksatiazinu
WO2015160928A3 (en) Isolated t cell receptors and methods of use therefor
WO2018152270A8 (en) Peptide-based synthetic molecules and silica nanostructures
JP2018500352A5 (enExample)
CY1118746T1 (el) Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων
JP2019505549A5 (enExample)
JP2017533483A5 (enExample)
HK1250020A1 (zh) 用於吡咯连接的二价化合物的化学合成的方法及其组合物
RU2013129265A (ru) Способ инкапсуляции фенбендазола
CN106414485A8 (zh) 人工活化的毒性肽